Skip to main content
. 2016 Dec 8;55(1):381–393. doi: 10.1080/13880209.2016.1241811

Figure 10.

Figure 10.

(A) Free radical scavenging assay of vitexin and standard BHT (20–100 μM) (A). (B) Acetylcholinesterase and (C) butyrylcholinesterase inhibitory effect of vitexin (20–100 μM) and the reference donepezil. *Significant level at p < 0.05 (control versus treated).